ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2534

The Intensive Diet and Exercise for Arthritis Trial (IDEA): 18-Month Radiographic and MRI Outcomes

David J. Hunter1, D. Beavers2, Felix Eckstein3, Ali Guermazi4, Richard F. Loeser5, Barbara J. Nicklas6, Shannon Mihalko7, Gary D. Miller7, Mary Lyles8, Paul DeVita9, Claudine Legault10, J. Jeffery Carr11, Jeff D. Williamson8 and Stephen P. Messier7, 1Rheumatology, Institute of Bone and Joint Research, Kolling Institute, University of Sydney, Sydney, Australia, 2Wake Forest University, Winston Salem, NC, 3Anatomy & Musculoskeletal Research, Paracelsus Medical University, Salzburg, Austria, 4Radiology, Boston University, Boston, MA, 5Section Of Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 6Center on Aging, Wake Forest University School of Medicine, Winston-Salem, NC, 7Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, 8Center on Aging, Wake Forest University School of Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, 9Department of Exercise and Sport Science, East Carolina University, Greenville, NC, 10Department of Public Health Sciences, Wake Forest University School of Medicine, Winston-Salem, NC, 11Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Magnetic resonance imaging (MRI), obesity, osteoarthritis and radiography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Osteoarthritis - Clinical Aspects I: Weight, Activity, and Metabolic Effects on Osteoarthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Dietary induced weight loss is a proven non-pharmacologic intervention for osteoarthritis. Based upon current literature it is unclear if weight loss modifies structural progression. We report the radiographic and MRI structural outcomes of an 18 month study  of intensive weight loss, with or without exercise compared to exercise alone in older, overweight and obese adults with symptomatic knee osteoarthritis.

Methods: The Intensive Diet and Exercise for Arthritis trial (IDEA) was a prospective, single-blind, randomized controlled trial that enrolled 454 overweight and obese (BMI = 27-42 kg/m2) older (age ≥ 55 yrs) adults with pain and radiographic evidence of tibiofemoral osteoarthritis (KL = 2-3). Participants were randomized to one of three 18-month interventions: intensive dietary weight loss-only (D);  intensive dietary weight loss-plus-exercise (D+E); or exercise-only control (E). X-rays and MRIs were acquired at baseline and 18 months of follow-up. Standardized weight bearing x-rays (N = 325) were acquired and joint space width (JSW) was measured (blinded to time point) using an automated algorithm for minimum JSW and JSW at 4 fixed locations in the medial compartment. MRIs were obtained on a subsample of study participants (N = 105) and tibiofemoral cartilage thickness measured and semi-quantitative (SQ) MRI scoring performed using BLOKS. We used an intention to treat analysis to compare change between groups at 18 month follow-up. X-ray and MRI results were analyzed using ANCOVA adjusted for baseline values, BMI, and gender. X-ray was also adjusted for inter-rim distance. Ordinal logistic regression was used for the ordinal SQ analyses, adjusting for baseline values, BMI and gender.

Results: Mean baseline descriptive characteristics of the cohort included: age, 65.6 yrs.; BMI 33.6 kg/m2; 72% female; 81% white. A total of 399 (88%) participants completed the study and returned for FU18mth testing. Mean weight loss was: D, -9.5%; D+E, -11.4%; E, -2.2%. There were no baseline differences between groups in JSWx (0.225) 4.5 (1.9)mm or for cartilage thickness of the medial tibia and central medial femur combined 2.90 (0.08)mm. All 3 groups demonstrated continued progression of JSW loss with no significant difference between groups D -0.07(0.22)mm, D+E -0.27(0.22)mm and E -0.16(0.24)mm (p=0.79). All 3 groups demonstrated continued progression of MRI cartilage loss with no significant difference between groups D -0.10(0.05) mm, D+E -0.13(0.04)mm and E -0.05(0.04)mm (p=0.42). Maximal bone marrow lesion (BML) size showed a trend to improvement for the D+E OR 0.70 (0.25-1.95) and D OR 0.44 (0.16 – 1.23) groups.

Conclusion: Despite the potent effects of weight loss on symptoms, there does not appear to be any amelioration in the rate of structural progression either on x-ray or MRI cartilage measurement. The evidence of a trend towards improvements in BML suggests that this may be one mechanism for the symptom improvements related to weight loss.

Supported by grants from NIH R01 AR052528, P30 AG21332, M01 RR00211


Disclosure:

D. J. Hunter,

ARC Future Fellowship,

2,

DonJoy,

2,

NIH,

2,

NHMRC,

2;

D. Beavers,
None;

F. Eckstein,

Chondrometrics,

3;

A. Guermazi,

BICL, LLC,

4,

AstraZeneca, Genzyme, Novartis, and MerckSerono,

5;

R. F. Loeser,
None;

B. J. Nicklas,
None;

S. Mihalko,
None;

G. D. Miller,
None;

M. Lyles,
None;

P. DeVita,
None;

C. Legault,
None;

J. J. Carr,
None;

J. D. Williamson,
None;

S. P. Messier,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-intensive-diet-and-exercise-for-arthritis-trial-idea-18-month-radiographic-and-mri-outcomes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology